Pacira BioSciences completes enrollment in knee osteoarthritis gene therapy trial
Tweet Send to a Friend
Pacira BioSciences Inc. (NASDAQ: PCRX) has completed patient enrollment in Part A of its Phase 2 ASCEND study evaluating PCRX-201 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
